Champions Oncology Inc

CSBR | Healthcare | NASDAQ
$6.66
-0.10 (-1.48%)

Key Metrics

Market Cap
$91.81M
P/E Ratio
31.71
EPS
$0.21
Beta
N/A
Dividend Yield
N/A
ROE
87.06%
Current Ratio
0.93

Company Information

Industry
Biotechnology

About Champions Oncology Inc

Champions Oncology Inc develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immunedeficient mice The company through its Tumorgraft Technology Platform provides personalized cancer care based upon the implantation of human tumors in immunedeficient mice It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process The company provides Lumin Bioinformatics a software platform and data tool that contains comprehensive information derived from research services and clinical studies and sold on an annual subscriptions basis The company markets its products through internet word of mouth and sales force to patients and physicians The company was formerly known as Champions Biotechnology Inc and changed its name to Champions Oncology Inc in April 2011 Champions Oncology Inc was incorporated in 1985 and is headquartered in Hackensack New Jersey

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-09-15 $-0.03 $0.01 -400.0%
2025-07-23 $-0.13 $0.06 -316.7%
2025-03-11 $0.31 $-0.01 +-3,200.0%
2024-12-11 $0.05 $0.01 +400.0%

Financial Ratios (TTM)

Gross Margin
32.48%
Operating Margin
6.29%
Net Margin
6.82%
ROA
9.57%
Price to Book
26.57
Price to Sales
2.17